Phenotypic outcomes in Mouse and Human Foxc1 dependent Dandy-Walker cerebellar malformation suggest shared mechanisms

  1. Parthiv Haldipur
  2. Derek Dang
  3. Kimberly A Aldinger
  4. Olivia K Janson
  5. Fabien Guimiot
  6. Homa Adle-Biasette
  7. William B Dobyns
  8. Joseph R Siebert
  9. Rosa Russo
  10. Kathleen J Millen  Is a corresponding author
  1. Seattle Children's Research Institute, United States
  2. SCRI, United States
  3. Seattle Chidren's Research Institute, United States
  4. INSERM UMR 1141, France
  5. Seattle Children's Hospital, United States
  6. S. Giovanni di Dio e Ruggi D'Aragona, Italy

Abstract

FOXC1 loss contributes to Dandy-Walker malformation (DWM), a common human cerebellar malformation.  Previously we found that complete Foxc1 loss leads to aberrations in proliferation, neuronal differentiation and migration in the embryonic mouse cerebellum (Haldipur et al., 2014). We now demonstrate that hypomorphic Foxc1 mutant mice have granule and Purkinje cell abnormalities causing subsequent disruptions in postnatal cerebellar foliation and lamination. Particularly striking is the presence of a partially formed posterior lobule echoing the posterior vermis DW "tail sign" observed in human imaging studies. Lineage tracing experiments in Foxc1 mutant mouse cerebella indicate aberrant migration of granule cell progenitors destined to form the posterior-most lobule causes this unique phenotype. Analyses of rare human del chr 6p25 fetal cerebella demonstrate extensive phenotypic overlap with our Foxc1 mutant mouse models, validating our DWM models and demonstrating that many key mechanisms controlling cerebellar development are likely conserved between mouse and human.

Article and author information

Author details

  1. Parthiv Haldipur

    Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Derek Dang

    CIBR, SCRI, SEATTLE, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Kimberly A Aldinger

    CIBR, SCRI, SEATTLE, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Olivia K Janson

    Center for Integrative Brain Research, Seattle Chidren's Research Institute, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Fabien Guimiot

    Hôpital Robert-Debré, INSERM UMR 1141, PARIS, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Homa Adle-Biasette

    Hôpital Robert-Debré, INSERM UMR 1141, PARIS, France
    Competing interests
    The authors declare that no competing interests exist.
  7. William B Dobyns

    CIBR, SCRI, SEATTLE, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Joseph R Siebert

    pathology, Seattle Children's Hospital, seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Rosa Russo

    University Medical College, S. Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy
    Competing interests
    The authors declare that no competing interests exist.
  10. Kathleen J Millen

    Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, United States
    For correspondence
    kathleen.millen@seattlechildrens.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9978-675X

Funding

National Institutes of Health (R01NS072441)

  • Kathleen J Millen

National Institutes of Health (R01NS080390)

  • Kathleen J Millen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Robb Krumlauf, Stowers Institute for Medical Research, United States

Ethics

Animal experimentation: All animal experimentation for this study was approved by the Institutional Animal Care and Use Committee (IACUC Protocol no 14208), of Seattle Children's Research Institute, Seattle, WA, USA..

Human subjects: All human studies were approved by Institutional Review Boards at all participating institutions. Written informed consent was obtained from all subjects.

Version history

  1. Received: August 23, 2016
  2. Accepted: January 15, 2017
  3. Accepted Manuscript published: January 16, 2017 (version 1)
  4. Version of Record published: January 27, 2017 (version 2)

Copyright

© 2017, Haldipur et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,587
    views
  • 281
    downloads
  • 29
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Parthiv Haldipur
  2. Derek Dang
  3. Kimberly A Aldinger
  4. Olivia K Janson
  5. Fabien Guimiot
  6. Homa Adle-Biasette
  7. William B Dobyns
  8. Joseph R Siebert
  9. Rosa Russo
  10. Kathleen J Millen
(2017)
Phenotypic outcomes in Mouse and Human Foxc1 dependent Dandy-Walker cerebellar malformation suggest shared mechanisms
eLife 6:e20898.
https://doi.org/10.7554/eLife.20898

Share this article

https://doi.org/10.7554/eLife.20898

Further reading

    1. Developmental Biology
    2. Physics of Living Systems
    Raphaël Clément
    Insight

    Geometric criteria can be used to assess whether cell intercalation is active or passive during the convergent extension of tissue.

    1. Computational and Systems Biology
    2. Developmental Biology
    Arya Y Nakhe, Prasanna K Dadi ... David A Jacobson
    Research Article

    The gain-of-function mutation in the TALK-1 K+ channel (p.L114P) is associated with maturity-onset diabetes of the young (MODY). TALK-1 is a key regulator of β-cell electrical activity and glucose-stimulated insulin secretion. The KCNK16 gene encoding TALK-1 is the most abundant and β-cell-restricted K+ channel transcript. To investigate the impact of KCNK16 L114P on glucose homeostasis and confirm its association with MODY, a mouse model containing the Kcnk16 L114P mutation was generated. Heterozygous and homozygous Kcnk16 L114P mice exhibit increased neonatal lethality in the C57BL/6J and the CD-1 (ICR) genetic background, respectively. Lethality is likely a result of severe hyperglycemia observed in the homozygous Kcnk16 L114P neonates due to lack of glucose-stimulated insulin secretion and can be reduced with insulin treatment. Kcnk16 L114P increased whole-cell β-cell K+ currents resulting in blunted glucose-stimulated Ca2+ entry and loss of glucose-induced Ca2+ oscillations. Thus, adult Kcnk16 L114P mice have reduced glucose-stimulated insulin secretion and plasma insulin levels, which significantly impairs glucose homeostasis. Taken together, this study shows that the MODY-associated Kcnk16 L114P mutation disrupts glucose homeostasis in adult mice resembling a MODY phenotype and causes neonatal lethality by inhibiting islet insulin secretion during development. These data suggest that TALK-1 is an islet-restricted target for the treatment for diabetes.